Sponsor:
EyeBiotech Ltd.
Code:
NCT07440225
Conditions
Macular Degeneration
Age-Related Macular Degeneration
Choroidal Neovascularization
Wet Macular Degeneration
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Interventions
Tiespectus
Aflibercept
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-01. This information was provided to ClinicalTrials.gov by EyeBiotech Ltd. on 2026-04-23.